Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Apr 15, 2020; 12(4): 457-466
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.457
Table 1 Reported series with perineural invasion in hilar cholangiocarcinoma
Ref.Number of patientNumber of PNI (%)Recurrence after curative resection (%)
Hu et al[1], 201925838.8 (100/258)70 (180/258)
Kovalenko et al[2], 20184983.3 (41/49)-
Ercolani et al[4], 20105175 (33/44)-
Young et al[5], 20105192 (47/51)-
Aishima et al[6], 20073876.3 (29/38)57.9 (22/38)
Robles et al[7], 20043664 (23/36)53.0 (19/36)
Nakagohri et al[9], 200326100 (26/26)-
Seyama et al[10], 20035884.5 (49/58)-
Nimura et al[11], 20004259.2 (84142)53.7 (58/108)
Nagakawa et al[12], 20004792.5 (43/47)-
Kurosaki et al[13], 19988388 (73/83)-
Yamaguchi et al[14], 19972475 (18/24)-
Su et al[15], 19964973.5 (36/49)-
Table 2 Clinicopathologic characteristics of patients
Characteristicsn (%)
Gender
Female33 (44)
Male42 ( 56)
Bismuth-Corlette classification
Type I19 (25.33)
Type II20 (26.67)
Type III20 (26.67)
Type IV16 (21.33)
Histological differentiation
Well9 (12)
Moderate35 (46.67)
Poor29 (38.67)
Mucinous2 (2.67)
Lymphatic invasion
No54 (72)
Yes21 (28)
Depth of tumor invasion
Within bile duct serosa2 (2.67)
Beyond bile duct serosa73 (97.33)
Perineural invasion
No6 (8)
Yes69 (92)